These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8214107)

  • 1. Tyrosine kinase inhibitors suppress endotoxin- and IL-1 beta-induced NO synthesis in aortic smooth muscle cells.
    Marczin N; Papapetropoulos A; Catravas JD
    Am J Physiol; 1993 Sep; 265(3 Pt 2):H1014-8. PubMed ID: 8214107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inhibition of inducible nitric oxide synthase by geldanamycin, a tyrosine kinase inhibitor, in endothelial, smooth muscle cells, and in rat aorta.
    Joly GA; Ayres M; Kilbourn RG
    FEBS Lett; 1997 Feb; 403(1):40-4. PubMed ID: 9038357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of tyrosine kinase in the LPS-promoted initiation of L-arginine-induced relaxation of rat aorta mediated by induction of no synthase.
    Moritoki H; Hisayama T; Takeuchi S; Kondoh W; Takeji Y
    Life Sci; 1995; 57(11):PL125-30. PubMed ID: 7544862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase activation is necessary for inducible nitric oxide synthase expression by interleukin-1 beta.
    Tetsuka T; Morrison AR
    Am J Physiol; 1995 Jul; 269(1 Pt 1):C55-9. PubMed ID: 7543244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta.
    Papapetropoulos A; Abou-Mohamed G; Marczin N; Murad F; Caldwell RW; Catravas JD
    Br J Pharmacol; 1996 Jul; 118(6):1359-66. PubMed ID: 8832057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase inhibitors, genistein and herbimycin A, do not block interleukin-1 beta-induced activation of NF-kappa B in rat mesangial cells.
    Tetsuka T; Srivastava SK; Morrison AR
    Biochem Biophys Res Commun; 1996 Jan; 218(3):808-12. PubMed ID: 8579596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets.
    Corbett JA; Kwon G; Marino MH; Rodi CP; Sullivan PM; Turk J; McDaniel ML
    Am J Physiol; 1996 Jun; 270(6 Pt 1):C1581-7. PubMed ID: 8764139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide enhances IL-1 beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
    Iimura O; Kusano E; Homma S; Takeda S; Ikeda U; Shimada K; Asano Y
    Kidney Blood Press Res; 1998; 21(1):36-41. PubMed ID: 9661135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotides and inducible nitric oxide synthesis in pulmonary artery smooth muscle.
    Hayden MA; Nakayama DK
    J Surg Res; 1999 Apr; 82(2):222-7. PubMed ID: 10090833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of nitric oxide synthase by protein synthesis inhibition in aortic smooth muscle cells.
    Marczin N; Go CY; Papapetropoulos A; Catravas JD
    Br J Pharmacol; 1998 Mar; 123(5):1000-8. PubMed ID: 9535031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
    Beasley D; McGuiggin M
    J Exp Med; 1994 Jan; 179(1):71-80. PubMed ID: 7505803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C and protein tyrosine kinase mediate lipopolysaccharide- and cytokine-induced nitric oxide formation in vascular smooth muscle cells of rats.
    Han YL; Kang J; Li SH
    Sheng Li Xue Bao; 2003 Jun; 55(3):265-72. PubMed ID: 12817292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
    Shimokado K; Umezawa K; Ogata J
    Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells.
    Akarasereenont P; Mitchell JA; Appleton I; Thiemermann C; Vane JR
    Br J Pharmacol; 1994 Dec; 113(4):1522-8. PubMed ID: 7534189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells.
    Kusano E; Tian S; Umino T; Tetsuka T; Ando Y; Asano Y
    J Hypertens; 1997 Jun; 15(6):627-32. PubMed ID: 9218182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP.
    Cornwell TL; Arnold E; Boerth NJ; Lincoln TM
    Am J Physiol; 1994 Nov; 267(5 Pt 1):C1405-13. PubMed ID: 7977701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
    Leduc I; Haddad P; Giasson E; Meloche S
    Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
    Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin induces endothelial barrier dysfunction through protein tyrosine phosphorylation.
    Bannerman DD; Goldblum SE
    Am J Physiol; 1997 Jul; 273(1 Pt 1):L217-26. PubMed ID: 9252559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.
    Hecker M; Preiss C; Schini-Kerth VB
    Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.